These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids. Song Z; He Y; Ma J; Fu PP; Lin G J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835 [TBL] [Abstract][Full Text] [Related]
3. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Bruner LH; Carpenter LJ; Hamlow P; Roth RA Toxicol Appl Pharmacol; 1986 Sep; 85(3):416-27. PubMed ID: 3094196 [TBL] [Abstract][Full Text] [Related]
4. Platelets and the puzzles of pulmonary pyrrolizidine poisoning. Roth RA; Ganey PE Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680 [TBL] [Abstract][Full Text] [Related]
5. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline. Huxtable RJ; Bowers R; Mattocks AR; Michnicka M Adv Exp Med Biol; 1991; 283():605-12. PubMed ID: 1906228 [No Abstract] [Full Text] [Related]
6. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver. Yan CC; Cooper RA; Huxtable RJ Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024 [TBL] [Abstract][Full Text] [Related]
7. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline. Lafranconi WM; Ohkuma S; Huxtable RJ Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082 [TBL] [Abstract][Full Text] [Related]
8. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. Roth RA; Reindel JF Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225 [TBL] [Abstract][Full Text] [Related]
9. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity. Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Yang M; Ruan J; Fu PP; Lin G Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561 [TBL] [Abstract][Full Text] [Related]
11. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Lafranconi WM; Huxtable RJ Biochem Pharmacol; 1984 Aug; 33(15):2479-84. PubMed ID: 6087830 [TBL] [Abstract][Full Text] [Related]
12. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat. Yan CC; Huxtable RJ Toxicon; 1995 May; 33(5):627-34. PubMed ID: 7660367 [TBL] [Abstract][Full Text] [Related]
14. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole. Hilliker KS; Roth RA Exp Lung Res; 1985; 8(4):201-12. PubMed ID: 4043006 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats. Mattocks AR; Driver HE Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746 [TBL] [Abstract][Full Text] [Related]
16. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110 [TBL] [Abstract][Full Text] [Related]
17. Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites. He Y; Lian W; Ding L; Fan X; Ma J; Zhang QY; Ding X; Lin G Arch Toxicol; 2021 Jan; 95(1):103-116. PubMed ID: 33033841 [TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes. Couet CE; Hopley J; Hanley AB Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199 [TBL] [Abstract][Full Text] [Related]
20. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity. Mattocks AR; Bird I Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]